Abstracts tagged "Sjogren’s syndrome and cryoglobulinemia"

Abstract Number: 2163 • 2014 ACR/ARHP Annual Meeting
Genetic Variants of TNFAIP3 in Patients with HCV Related Lymphoma Are Associated with the Presence of Rheumatoid Factor (RF)
Gaetane Nocturne¹, Saida Boudaoud², Caroline Besson³, Frederic Davi⁴, Danielle Canioni⁵, Patrice Cacoub⁶, Olivier Hermine⁷ and Xavier Mariette⁸, ¹INSERM U1012, Paris sud university, Le Kremlin Bicetre, France, ²Université Paris-Sud, INSERM U1012, Le Kremlin Bicêtre, France, ³Paris Sud University, Le Kremlin Bicêtre, France, ⁴Department of Pathology, Hôpital de la Pitié Salepetrière, Paris, France, ⁵Service d'anatomo-pathologie, Hôpital Necker,, Paris, France, ⁶Groupe Hospitalier Pitié Salpétrière, Service de Médecine Interne, DHU i2B, Paris, France, ⁷Service d'hématologie, Centre de référence des mastocytoses, Hôpital Necker Enfants malades, Université Paris V, IFR Necker,, Paris, France, ⁸rheumatology, Université Paris-Sud, Le Kremlin Bicêtre, France
Background/Purpose: HCV chronic infection is associated with an increased risk of non-Hodgkin lymphoma (NHL) occurrence. HCV-associated NHL share homologies with primary Sjögren Syndrome (pSS)-associated NHL,…
Abstract Number: 2183 • 2012 ACR/ARHP Annual Meeting
Common Features in Lymphoproliferative Complications in the Course of Primary Sjögren’s Syndrome: Results From a Multicenter Cohort of 1170 Patients
Luca Quartuccio¹, Chiara Baldini², Roberta Priori³, Elena Bartoloni Bocci⁴, Francesco Carubbi⁵, Miriam Isola⁶, Marta Maset⁷, Sara Salvin⁷, Nicoletta Luciano², Giovanna Picarelli⁸, Alessia Alunno⁹, Roberto Giacomelli¹⁰, Roberto Gerli¹¹, Guido Valesini¹², Stefano Bombardieri¹³ and Salvatore De Vita¹, ¹Rheumatology, DSMB, University Hospital Santa Maria della Misericordia, Udine, Italy, ²University of Pisa, Rheumatology Unit, Pisa, Italy, ³Department of Internal Medicine and Medical Specialties, Sapienza University, Rome, Italy, ⁴Rheumatology Unit, Department of Clinical & Experimental Medicine, University of Perugia, Perugia, Italy, ⁵Rheumatology Clinic, University of L'Aquila, L'Aquila, Italy, ⁶Institute of Statistics, University of Udine, Udine, Italy, ⁷Rheumatology Clinic, DSMB, University of Udine, Italy, Udine, Italy, ⁸Rheumatology Unit, Sapienza University of Rome, Rome, Italy, ⁹Clinical and Experimental Medicine, Rheumatology Unit, University of Perugia, Perugia, Italy, ¹⁰Rheumatology Unit, University of Aquila, L'Aquila, Italy, ¹¹Rheumatology Unit, University of Perugia, Perugia, Italy, ¹²Clinica e Terapia Medica, Sapienza, Universita di Roma, Rome, Italy, ¹³Department of Clinical and Experimental Medicine, Rheumatology Unit, University of Pisa, Pisa, Italy
Background/Purpose: To describe the prevalence of lymphoproliferative complications (defined as B-cell lymphoma or definite conditions predisposing to lymphoma, i.e, cryoglobulinemic vasculitis (CV) and major salivary…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].